Pirtobrutinib
Eli Lilly
['pirto', 'cll']
#cll #eha2023 j brown. pirtobrutinib in rr cll
orr 80%
51% btkmut at baseline. 75% acquired further mutations, 45% were new btkmut (t474 &amp; l528)
25% of new btkmut were at baseline (clonal selection) 